Systematic Characterization of Clinically Actionable Antibody-Drug Targets Across Solid Tumors to Advance Precision Oncology
Crossref REST API · 學術索引收錄 · 來源發佈:Wed Nov 18 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · 本站收錄:Wed Nov 18 2026 15:09:25 GMT+0000 (Coordinated Universal Time)
已保存的原文節選
Abstract The rapid expansion of antibody therapeutics is shifting the clinical bottleneck from drug availability to precise patient selection. We systematically characterize 87 clinically actionable tumor-associated antigens across solid tumors by integrating transcriptomic, proteomic, spatial, and single-cell profiles from more than 32,000 specimens to define expression prevalence, intratumoral h
以上為帶出處的原文節選,完整內容請閱讀原始鏈接。自動收錄與主題分類不等於事實核驗。